Epidemiology and Nomenclature

Chapter 1: Epidemiology and Nomenclature

This slide module will give an overview of the epidemiology of HDL, the history of HDL-C as a therapeutic target, how HDL-C is associated with CVD Outcomes and an overview of measures of HDL quantity.


Peter P. Toth, MD, PhD, FNLA

Rachel H. Mackey, PhD, MPH

Richard H. Karas, MD, PhD

View Slides with Notes Download Full Size Slides Download Slides with Notes
No votes yet
Activity Classification

This activity is instructional only and may not be taken for credit.

Content Domain
This activity falls under the following content domain(s):

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Evaluate the role of HDL-C in reducing cardiovascular events and rates of atherosclerotic disease progression
  2. For Registered Nurses and Nurse Practitioners Only: Provide appropriate care and counsel for patients and their families

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service